“…Cultures that reached 50–70% confluence in flasks were serum starved for 24 h, followed by treatment with TGF-β1 (T7039, Sigma Aldrich, St. Louis, MO, USA) at different concentrations (3 ng/mL, 5 ng/mL, 10 ng/mL, 15 ng/mL) for 24 h, 36 h, 48 h, 72 h, and 96 h while one set, that was left untreated, was used as control. Cell viability in control and treated cells was measured using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT, Sigma-Aldrich, St. Louis, MO, USA) assay using a previously described procedure [ 14 ]. Cells were serum starved for 24 h and then treated with or without TGF-β1 (3 ng/mL, 5 ng/mL, 10 ng/mL, 15 ng/mL) for 24 h, 36 h, 48 h, 72 h, and 96 h. Absorbance at 570 nm was measured on an EPOCH microplate reader (BioTek, Winooski, VT, USA).…”